GlaxoSmithKline (GSK) has announced it is to begin searching for a successor to CEO Andrew Witty, who will retire in just over a year's time. Witty has told GSK's board that he intends to retire ...

GlaxoSmithKline’s (GSK) former chief executive Andrew Witty was yesterday announced as the new CEO of Optum – a US payer organisation which includes pharmacy benefits manager OptumRx.

Since the assassination of his top lieutenant Brian Thompson on Dec. 4, Andrew Witty ... A spokeswoman for GSK declined to comment. Witty worked to remake GSK’s image. Greater access to drugs ...

Andrew Witty became CEO of UnitedHealth Group in 2021, but this isn’t his first medical executive gig—he also served as CEO of leading pharmaceutical manufacturer GlaxoSmithKline from 2008 to ...